Why the study?
Routine use of active mechanical circulatory support (MCS) in infarct-related cardiogenic shock (AMI-CS) remains controversial, and the influence of sex on MCS efficacy is poorly defined.
Does early routine active mechanical circulatory support (MCS) reduce 6-month all-cause mortality differently by sex in patients with infarct-related cardiogenic shock (AMI-CS)?
Meta-Analysis (n=1,058)
Randomized trials
Yes
Does early routine active mechanical circulatory support (MCS) reduce 6-month all-cause mortality differently by sex in patients with infarct-related cardiogenic shock (AMI-CS)?
Answers are grounded in this paper and cite their sources.
In patients with infarct-related cardiogenic shock, early routine mechanical circulatory support showed no overall sex-specific difference in 6-month mortality reduction, though subgroup analysis of DanGer-Shock-like patients suggested a mortality benefit in men but not women.
BACKGROUND: Routine use of active mechanical circulatory support (MCS) in infarct-related cardiogenic shock (AMI-CS) remains controversial. Although recent evidence suggests potential benefit in selected patients, the influence of sex on MCS efficacy is poorly defined. AIMS: To evaluate whether sex modifies the effect of MCS in AMI-CS. METHODS: Randomized trials comparing early routine MCS with standard care in AMI-CS and reporting 6-month mortality were identified through January 2025. Individual patient data were analyzed using study-stratified Cox models. The primary outcome was 6-month all-cause mortality. Secondary outcomes included 30-day mortality, major bleeding, and peripheral ischemic vascular complications. RESULTS: Nine trials including 213 (20%) female and 845 male patients were analysed. Women were older than men (67.6 vs. 63.7 years; P < 0.001) and had higher 6-month mortality (60% vs. 52%; P = 0.03). Early routine MCS was not associated with significantly lower mortality in either women (HR, 0.99; 95% CI, 0.70-1.42) or men (HR, 0.84; 95% CI, 0.70-1.02; P for interaction = 0.41). Among DanGer Shock-like patients, MCS was associated with lower mortality in men (HR, 0.66; 95% CI, 0.51-0.86), but not in women (HR, 1.18; 95% CI, 0.72-1.91; P for interaction = 0.02). MCS increased complications in both sexes. CONCLUSIONS: Women with AMI-CS were underrepresented and had higher mortality than men. No sex-specific treatment effect was observed overall, whereas subgroup findings suggested possible heterogeneity in DanGer-Shock-like patients. These findings, limited by small number of female patients and wide confidence intervals, support the need for adequately powered trials with sufficient female representation.
No takes yet. Share an insight, caveat, or question.
Buellesbach et al. (2026) conducted a meta-analysis in Infarct-related cardiogenic shock (AMI-CS) (n=1,058). Early routine active mechanical circulatory support (MCS) vs. Standard care was evaluated on 6-month all-cause mortality (HR 0.99 in women; HR 0.84 in men, 95% CI 0.70-1.42 in women; 0.70-1.02 in men, p=0.41 for interaction).
Synapse has enriched 10 related papers. Consider them for comparative context: